About this trial
The study attempts to quantify the relative risks for mortality, anastomotic leakage and other early and late postoperative complications, recurrence rate, cancer-specific survival, recurrence-free survival after colorectal surgery for patients with colorectal cancer depending on the localization of the tumor.
Eligibility criteria
Qualifiers
Histologically proven primary adenocarcinoma of bowel;
All patients who have indications for surgical treatment of colorectal cancer based on the decision of the oncological council;
Signed informed consent with agreement to attend all study visits;
Disqualifiers
Unresectable tumor or contradictions to surgery;
Indications for chemotherapy or radiation therapy prior to surgery;
Patient withdrawal from the trial or loss of follow-up;
Emergent operation;
Trial design
Treatments tested in this trial
- Right hemicolectomy
- Left hemicolectomy
- Sigmoid colon resection
- Anterior resection of the rectum
- Low anterior resection of the rectum
- Abdominoperineal resection
- Total Colectomy
Treatment groups
Sponsors and collaborators
Immanuel Kant Baltic Federal University
Lead sponsor
Center of Endourology "Endocenter"
Collaborator